Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW031 and Prolia® in Healthy Adults
Clinical trial NCT04798313 · COMPLETED
Trial details
- NCT number
- NCT04798313
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-02
- Primary completion
- 2020-12-07
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.